FDA NDC

STELARA

This name is from the loaded FDA file.

Source: FDA NDC Directory, live from openFDA. Publisher page

NDC
57894-060
Proprietary name
STELARA
Nonproprietary name
ustekinumab
Labeler
Janssen Biotech, Inc.
Dosage form
INJECTION, SOLUTION
Strength
45 mg/.5mL

Run it in Rivvi

Which 2027 plans near you dropped or restricted ustekinumab?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Try it on your own data today.

Free to start. Most teams are using it the same day.